Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to September 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $132.4B |
| Sales growthchange from the year before | +32.5% |
| Gross marginshare of sales left after the direct cost of what it sells | 3.1% |
| Net marginshare of sales kept as profit | 0.2% |
| Free-cash-flow marginspare cash generated per $100 of sales | 3.3% |
| Return on equityprofit vs. shareholders' accounting value | 12.1% |
| Change in share countnegative = the company is buying back its shares | +5.7% |
6 insiders sold $26.6M (all under pre-arranged plans) on the open market.
| Rotsztain DiegoChief Governance/Legal Officer | Sold (plan)Jul 24 | 20,630 shat $74.40 · $1.5M |
| Oconnor Sean MichaelExecutive Vice-Chairman-Board · Director | Sold (plan)Jul 22 | 104,934 shat $74.33 · $7.8M |
| Dunaway William JChief Financial Officer | Sold (plan)Jul 22 | 95,970 shat $74.33 · $7.1M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy